DocuSign reports Q2 FY27 results on September 3 — and the market is arriving more hedged than it has been in months, even as the stock has staged a sharp recovery.
Options positioning has turned the most defensive it has been in at least a year. The put/call ratio hit 1.17, more than two standard deviations above its 20-day average of 1.07 — its highest reading since at least July 2025. That's a meaningful shift. It tells you that money is actively moving into downside protection right before the print, not just sitting on the sidelines. The ratio has climbed steadily for eight straight sessions, which rules out noise.
Short positioning adds another cautious layer. Short interest has climbed 5.3% on the week to 6.8% of the free float — roughly 13.7 million shares — reversing what had been a sustained multi-week cover. A month ago, shorts held closer to 7.9% of the float; the unwind ran hard through August, pushing the stock up nearly 18% over the past month. That move now appears to be drawing fresh shorts back in. Days-to-cover, per FINRA's latest fortnightly data, sit at 5.3 days — not extreme, but meaningful for a name with this kind of volatility history around earnings. Borrowing costs remain essentially negligible at 0.38%, and availability is wide open — the borrow market has no friction at all, so there's nothing mechanically forcing shorts to cover.
The Street is broadly cautious despite the rally. The consensus mean price target is $58.76 — nearly 9% below where the stock closed Tuesday at $64.64. That gap is the clearest signal of analyst discomfort with the valuation at current levels. The sole recent upgrade came from BTIG, which raised its target to $75 from $60 on September 2 while keeping its Buy rating — a constructive move ahead of the print. But the broader analyst picture is more restrained: Citizens reaffirmed a Market Outperform with an $86 target in August, yet most of the post-June-earnings adjustments were neutral to negative, with Citi, Jefferies, Wells Fargo, and Wedbush all holding neutral or equal-weight ratings with targets between $50 and $58. The EV/EBITDA multiple of around 9x has drifted higher over the past month alongside the price, narrowing the margin of safety the bears need to make their case. Factor scores sit in the middle of the distribution — the short score ranks in the 33rd percentile, and EPS momentum trails the broader universe on both the 30-day and 90-day horizons.
The earnings history is the sharpest piece of context here. The last print, on June 4, produced a 9.8% one-day drop and a 15% decline over the following five days. Revenue came in at $830.2 million — up 9% year-on-year, with international sales growing 17% — but it wasn't enough. The bears point to slowing enterprise sales cycles and pricing pressure in larger deals; the bulls point to the Agreement Cloud expansion and growing IAM ARR, which is on track to represent 18% of total ARR. The question going into tomorrow is whether the current print can break that pattern or whether the stock's 18% monthly run has already priced in the good news.
Close peers moved broadly in step with DOCU this week. GWRE and BOX both gained around 6-7%, while PATH outperformed the group with nearly 9% gains. Wednesday's single-day pullback of 2.5% for DOCU was roughly in line with the sector — FRSH fell 3.3% and HUBS dropped 3.9% on the same day. That suggests the softness isn't name-specific; it's a sector exhale after a strong week. What makes DOCU distinct is the combination of a live earnings catalyst, rising short interest, and options positioning at a 52-week extreme — all converging on the same session.
The release after market close on September 3 is where all of this resolves. Enterprise deal velocity, IAM ARR trajectory, and any update on federal contract momentum are the specific metrics that will determine whether options hedgers collected their premium or got run over.
See the live data behind this article on ORTEX.
Open DOCU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
